Helmut Schuhsler Acer Therapeutics Inc

As of August 22, 2018


What is Helmut Schuhsler's Net Worth?

The current estimated net worth of Acer Therapeutics Inc's Helmut Schuhsler is estimated to be about $165.25M . Helmut Schuhsler owns about 1,697,709 units of Acer Therapeutics Inc common stock. In the last year at Acer Therapeutics Inc, Helmut Schuhsler has sold an estimated value of $0 worth.

What is Helmut Schuhsler's Past Insider Trading?

Helmut Schuhsler's largest purchase order was 275,000 units , worth over $4.95M on August 22, 2018. In total, Helmut Schuhsler has made about 3 transactions over a year of their time at Acer Therapeutics Inc. Helmut Schuhsler usually trades in January, September and August, with the busiest year in 2018.

TVM Life Science Ventures VII LP, Hubert Birner, Luc Marengere, Stefan Fischer, HELMUT SCHUHSLER, Reshentha Beeby, Gary Leatt

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Helmut Schuhsler's' Mailing Address?

  • Mailing address is C/o Tvm Techno Venture Management Maximillianstr. 35, Entrace C D- Munich 2M 80539 Germany

Acer Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Other Compensation
Total
Chris Schelling 2020 $436,000 $239,800 - - $675,800
Chris Schelling 2019 $436,000 - $1,031,211 - $1,467,211
Harry S. Palmin 2020 $382,400 $152,960 - - $535,360
Harry S. Palmin 2019 $382,400 - $462,041 - $844,441
Donald R. Joseph 2020 $350,200 $140,080 - - $490,280
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1069308/000119312521119320/d57953ddef14a.htm

What are Acer Therapeutics Inc's Past Insider Trades?

Acer Therapeutics Inc's most recent insider trade came on December 13, 2021 by Steve Aselage who bought 10,000 units worth $20.62K . In the last 4 years, insiders at Acer Therapeutics Inc have sold an estimated value of $10.31K and bought an estimated value of $9.8M worth of shares. Insider trading is most common in January, with the busiest year in 2019. The most active traders at the company are Steve Aselage, Director,  Michael John Dunn, Director,  and Chris Schelling, President & CEO .

Acer Therapeutics Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1